ClinicalTrials.gg
Not yet recruitingNCT07937917Updated Nov 16, 2026

Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury

An interventional study of Multisegment Transcutaneous Spinal Cord Stimulation (scTS) and Activity-Based Training (ABT) in Spinal Cord Injuries (Complete and Incomplete), sponsored by Dr. Gabriel Zeilig. Not yet recruiting at 1 site in Israel. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Dr. Gabriel Zeilig · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 11 studies in Spinal Cord Injuries with a site in Israel — 5 open to participants now, 5 under way, none of them phase 3. Spinal Cord Injuries · Israel.

Started
2027
the only one that year
No phase
6 of 11
5 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Dr. Gabriel Zeilig

Among the 11 studies in Spinal Cord Injuries with a site in Israel, this one is the only one that started in 2027, is one of 6 with no phase, and was the 11th registered.

Spinal Cord Injuries

2,028 studies on the registry are indexed under Spinal Cord Injuries; 538 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

5 of the 11 studies in Spinal Cord Injuries with a site in Israel are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 375 Spinal Cord Injuries studies recruiting now, 166 (44%) set no upper age limit and 158 (42%) stop at 75 or younger; 41 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Spinal Cord Injuries with a site in Israel, or all of them as a file.
02

Study summary

This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.

The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.

Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.

Read the detailed description

This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.

The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.

The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.

Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.

03

Conditions studied

  • Spinal Cord Injuries (Complete and Incomplete)

Keywords

  • Transcutaneous spinal cord stimulation
  • Neuromodulation
  • Spinal cord rehabilitation
  • Electromyography
  • Motor recovery
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 18 years of age.
  2. Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
  3. At least 6 months post spinal cord injury.
  4. Stable medical condition.
  5. Neuromuscular Recovery Scale (NRS) score \<4C on any upper extremity, trunk, or standing/stepping item.

Exclusion criteria

Exclusion Criteria:

  1. Ventilator dependence.
  2. Untreated or unstable fracture or pressure ulcer.
  3. Untreated psychiatric disorder or ongoing drug abuse.
  4. Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
  5. Skeletal muscle Botox injections within the previous 6 months.
  6. Previous nerve or tendon transfer of the arms or legs.
  7. Any implanted pump (e.g., baclofen pump or pain pump).
  8. Unable or unwilling to discontinue anti-spasticity medications.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Multisegment scTS + Activity-Based Training

    Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours.

    Device: Multisegment Transcutaneous Spinal Cord Stimulation (scTS) · Other: Activity-Based Training (ABT)

Interventions

  • DeviceMultisegment Transcutaneous Spinal Cord Stimulation (scTS)

    Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training.

  • OtherActivity-Based Training (ABT)

    Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation.

06

What researchers measure

Primary outcomes

  1. Motor Function (NRS)

    Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

  2. Safety

    Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness.

    Time frame: From enrollment through the final study assessment (approximately 7-10 months per participant).

Secondary outcomes

  1. Change in Surface EMG Amplitude During Functional Motor Tasks

    Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

  2. Depression (PHQ-9)

    Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

  3. Anxiety (GAD-7)

    Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

  4. PTSD (PCL-5)

    Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)

  5. PTSD (CAPS-5)

    Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity.

    Time frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

  6. Change in ISNCSCI Total Motor Score

    Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function.

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

  7. Change in Modified Ashworth Scale (MAS) Score

    Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement.

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

  8. Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score

    Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days.

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

  9. Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score

    Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire.

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

  10. Change in Modified Functional Reach Test Distance

    Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

  11. Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score

    Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32.

    Time frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2029, 24 months later.

Of 790 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 24 months is below that.

Counting every sponsor, half of 839 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 16, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Jan 1, 2029
CompletionEst.
Jan 1, 2030
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937917
Lead sponsor
Dr. Gabriel Zeilig
Responsible party
Dr. Gabriel Zeilig (Principal Investigator, Sheba Medical Center) — Sponsor-investigator
First posted
Nov 16, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jan 1, 2029 (estimated)
Completion
Jan 1, 2030 (estimated)
Last update
Nov 16, 2026

Study contacts

Amihai Gottlieb, Ph.D
Contact
amihai.gottlieb@gmail.com
+972543323180

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion